VQI DELTA Paclitaxel Device Safety Analysis

CompletedOBSERVATIONAL
Enrollment

219,483

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

April 1, 2020

Conditions
Peripheral Vascular Disease
Interventions
DRUG

Paclitaxel

Paclitaxel to treat peripheral arterial disease

DEVICE

Non-drug coated Device Treatment

Trial Locations (1)

01805

Lahey Clinic, Inc., Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Society for Vascular Surgery Patient Safety Organization

OTHER

lead

Lahey Clinic

OTHER